| Dr Peter C Morris, MD | |
|
4101 Tiger Lily Rd Ste 100, Lincoln, NE 68516-5587 | |
| (402) 420-7000 | |
| (402) 420-6969 |
| Full Name | Dr Peter C Morris |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 41 Years |
| Location | 4101 Tiger Lily Rd Ste 100, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912962994 | NPI | - | NPPES |
| 1912962994 | Medicaid | IA | |
| P0093054 | Other | NE | RAILROAD MEDICARE |
| 10025044500 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 18771 (Nebraska) | Secondary |
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 18771 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryan Medical Center | Lincoln, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cancer Partners Of Nebraska Pc | 9436148426 | 26 |
News Archive
SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.
Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
With the number of maternal deaths on the rise in the United States, researchers found that a drug frequently used to augment or induce labor may contribute to postpartum bleeding, a study in the September issue of Anesthesiology notes.
The Alberta Children's Hospital Foundation received a gift of $2.5 million today from the Kids Cancer Care Foundation of Alberta in support of childhood cancer research at the Alberta Children's Hospital, as well as the Alberta Children's Hospital Research Institute for Child and Maternal Health and the Southern Alberta Cancer Research Institute - both at the University of Calgary.
› Verified 5 days ago
| Entity Name | Nebraska Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628372 PECOS PAC ID: 6901707447 Enrollment ID: O20040116000781 |
News Archive
SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.
Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
With the number of maternal deaths on the rise in the United States, researchers found that a drug frequently used to augment or induce labor may contribute to postpartum bleeding, a study in the September issue of Anesthesiology notes.
The Alberta Children's Hospital Foundation received a gift of $2.5 million today from the Kids Cancer Care Foundation of Alberta in support of childhood cancer research at the Alberta Children's Hospital, as well as the Alberta Children's Hospital Research Institute for Child and Maternal Health and the Southern Alberta Cancer Research Institute - both at the University of Calgary.
› Verified 5 days ago
| Entity Name | Cancer Partners Of Nebraska Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437111408 PECOS PAC ID: 9436148426 Enrollment ID: O20040506000756 |
News Archive
SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.
Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
With the number of maternal deaths on the rise in the United States, researchers found that a drug frequently used to augment or induce labor may contribute to postpartum bleeding, a study in the September issue of Anesthesiology notes.
The Alberta Children's Hospital Foundation received a gift of $2.5 million today from the Kids Cancer Care Foundation of Alberta in support of childhood cancer research at the Alberta Children's Hospital, as well as the Alberta Children's Hospital Research Institute for Child and Maternal Health and the Southern Alberta Cancer Research Institute - both at the University of Calgary.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter C Morris, MD 4101 Tiger Lily Rd Ste 100, Lincoln, NE 68516-5587 Ph: (402) 420-7000 | Dr Peter C Morris, MD 4101 Tiger Lily Rd Ste 100, Lincoln, NE 68516-5587 Ph: (402) 420-7000 |
News Archive
SXC Health Solutions Corp. a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a three-year contract valued at approximately $240 million per year with a large Health Plan based on the U.S. east coast.
Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).
Nimbus Discovery LLC, a biopharmaceutical company using state-of the-art computational technology to discover novel medicines against exciting but difficult-to-drug disease targets, today announced an extension of its seed round with an investment by Bill Gates and Dr. Richard Friesner, the co-founder of Schrödinger and Professor of Chemistry at Columbia University. Atlas Venture, the founding investor, also participated.
With the number of maternal deaths on the rise in the United States, researchers found that a drug frequently used to augment or induce labor may contribute to postpartum bleeding, a study in the September issue of Anesthesiology notes.
The Alberta Children's Hospital Foundation received a gift of $2.5 million today from the Kids Cancer Care Foundation of Alberta in support of childhood cancer research at the Alberta Children's Hospital, as well as the Alberta Children's Hospital Research Institute for Child and Maternal Health and the Southern Alberta Cancer Research Institute - both at the University of Calgary.
› Verified 5 days ago
Todd D Martin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6050 Village Dr, Lincoln, NE 68516 Phone: 402-421-8581 Fax: 402-421-8594 | |
Meggan L Linck, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1001 S 70th St Ste 220, Lincoln, NE 68510 Phone: 402-486-4800 Fax: 402-853-5465 | |
Dr. Yvonne K Davenport, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9110 Andermatt Dr Ste 2, Lincoln, NE 68526 Phone: 402-483-7641 Fax: 402-483-0527 | |
Dr. Torri Marie Janecek, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5055 A St Ste 200, Lincoln, NE 68510 Phone: 402-483-8630 Fax: 402-483-8578 | |
Sharon L Hier-duffin, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7001 A St, Ste 200, Lincoln, NE 68510 Phone: 402-488-4022 Fax: 402-488-4113 | |
Maureen Patrice Malee, MD PHD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1500 S 48th St, Suite 712, Lincoln, NE 68506 Phone: 402-483-8485 Fax: 402-483-8486 | |
Dr. Robert Thomas Byington, MD OBGYN Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1530s 70th St 100, Lincoln, NE 68506 Phone: 402-488-2348 Fax: 402-488-2463 |